Clinical Trial Update: Effect of Different Doses of AMG 706 on the Gallbladder in Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the effects of different AMG 706 doses on the gallbladder in patients with advanced solid tumors; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• AMG 706 (motesanib)

Snippet

Sponsor: Amgen | Conditions: Solid Tumors | Phase 1 | Status: COMPLETED